Objectives

1. Describe the mechanism of action of leflunomide and significance of teriflunomide

2. Explain the role of pharmacogenomics within rheumatology and the relationship between CYP1A2 and leflunomide

3. Summarize the journal article and its aims, methods, and results

4. Discuss the strengths and weaknesses of the study as well as the overall findings of the journal article and their significance to clinical care

Session date: 
Tuesday, January 29, 2019 - 8:30am to 9:30am
Speaker Name: 
Pankti Reid, MD MPH
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.